Study # SURVENT

A Multicenter Randomized Controlled Trial of Surveillance vs. Endoscopic Therapy for Barrett’s Esophagus with Low-grade Dysplasia

Study Status:

Enrolled

Treatment Agent:

Not Applicable

Description

Short Title: SURVENT 

The trial’s primary aim is to determine if patients undergoing endoscopic eradication therapy will demonstrate less neoplastic progression and a lower incidence of esophageal adenocarcinoma compared to patients undergoing surveillance. 

Resources and Links

National Clinical Trial Identified Number: NCT05753748

Information and next steps

Disease:

  • Barrett’s Esophagus with Low-grade Dysplasia,
  • Esophageal Adenocarcinoma

Study Phase:

Not Applicable

Physician Name:

Department:

Ask a Question